Medication Systems Clinical Trial
Official title:
Improving Over-the-counter Medication Compliance.
| Verified date | November 2009 |
| Source | Florida Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
There are several benefits of over-the-counter medications, yet there is little research evaluating how to increase patient compliance when a health care provider suggests an over-the-counter (OTC) medication. We are evaluating two types of physician directions to see which increases patient compliance with OTC medications.
| Status | Completed |
| Enrollment | 246 |
| Est. completion date | February 2009 |
| Est. primary completion date | November 2008 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 19 Years to 50 Years |
| Eligibility |
Inclusion Criteria: - Female patients undergoing annual gynecologic examinations. - Ages 19-50. - Patients not currently taking certain OTC medications. Exclusion Criteria: - Pregnancy. - History of hypercalcemia. - History of kidney stones. - Outside study age range of 19-50. - Patient taking thyroid medication. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United States | Loch Haven Ob/Gyn Group | Orlando | Florida |
| Lead Sponsor | Collaborator |
|---|---|
| Florida Hospital |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Determining which of 2 types of physician direction regarding OTC medication usage improves patients compliance, as assessed at 3 and 6 months after enrollment. | 3 and 6 months after enrollment. | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05133700 -
Use and Opinions of Care Home Medicines Audit Tools
|
||
| Completed |
NCT03799367 -
The Feasibility of Drug Delivery to Infants During Breastfeeding
|
N/A |